New Head of Asia-Pacific Clinical Trial Services Appointed by Inceptua 

Inceptua Group has announced that Philip Gregory has joined Inceptua as Vice President, Head of Asia-Pacific, Clinical Trial Services.

Inceptua has offices in both Japan and China where the regional Clinical Trial Services Team provides strategic sourcing and supply of clinical trial materials with associated clinical packaging and labelling solutions, supporting trial sponsors and helping them realize their business goals in Asia and globally. 

"We have been actively operating in Asia for almost 20 years, and we are continuing to expand our capabilities throughout the APAC region. With Philip’s appointment we are further strengthening our representation in Asia as we see significant potential to increase our services to our existing customers and grow new business. China is already an important focus of our business due to the increasing number of clinical trials and improved regulatory climate," said Mark Ware, Executive Vice President, Clinical Trial Services.

Philip Gregory is an experienced international pharmaceutical professional having worked for over 25 years in large pharma, biotech, medical device, and CRO industries, with the majority of this time spent in Asia. Philip has lived and worked in Japan and Hong Kong and has spent the last 12 years in China, now joining Inceptua following seven years as Managing Director of George Clinical in Beijing.

"The clinical trials market in Asia is growing, and there is an increasing need for high quality comparator sourcing and clinical trial services in the region. Inceptua is a leading company in the field, with a unique service offering, and I look forward to working with existing and new clients to assist them in providing high quality medications for patients in their trials and in helping them to effectively run their trials in Asia," said Philip Gregory.